Time course for development of benzodiazepine tolerance and physical dependence
- PMID: 2858077
- DOI: 10.1016/0149-7634(85)90038-7
Time course for development of benzodiazepine tolerance and physical dependence
Abstract
Chronic benzodiazepine treatment elicits adaptive responses in the CNS, seen behaviorally as functional tolerance and physical dependence. Experiments are described in which a radioreceptor assay is used to follow benzodiazepine activity in CSF samples during daily flurazepam treatment of cats. Tolerance is evident even after the second dose, despite increasing CSF drug activity, showing a large and rapidly developing functional tolerance. Other studies are discussed which also show tolerance within 24 hours of initiating benzodiazepine treatment. In contrast, a spontaneous withdrawal syndrome is usually seen only after prolonged treatment with high doses. However, physical dependence can also be studied by precipitating abstinence with a benzodiazepine antagonist, such as Ro15-1788. Cats were treated daily with flurazepam, then Ro15-1788 was given and abstinence signs were recorded. Abstinence could be precipitated 24 hours after beginning treatment, and dependence was nearly maximal after 7 days. Dependence developed during treatment with as little as 0.5 mg/kg flurazepam, which is near threshold for any behavioral response. Chronic diazepam caused the same dependence as flurazepam. Thus, the development of tolerance and physical dependence both show a remarkably rapid adaptation of the CNS in response to benzodiazepines.
Similar articles
-
Blood pressure response to Ro15-1788, a benzodiazepine antagonist.Life Sci. 1985 Feb 25;36(8):781-7. doi: 10.1016/0024-3205(85)90199-7. Life Sci. 1985. PMID: 3919233
-
An antagonist-induced benzodiazepine abstinence syndrome.Eur J Pharmacol. 1982 Jun 16;81(1):153-7. doi: 10.1016/0014-2999(82)90616-1. Eur J Pharmacol. 1982. PMID: 6811290
-
Effects of repeated RO 15-1788 administration in benzodiazepine-dependent baboons.Eur J Pharmacol. 1985 Apr 2;110(2):257-61. doi: 10.1016/0014-2999(85)90220-1. Eur J Pharmacol. 1985. PMID: 2859217
-
Benzodiazepine dependence and its treatment with low dose flumazenil.Br J Clin Pharmacol. 2014 Feb;77(2):285-94. doi: 10.1111/bcp.12023. Br J Clin Pharmacol. 2014. PMID: 23126253 Free PMC article. Review.
-
Pharmacologic aspects of benzodiazepine tolerance and dependence.J Subst Abuse Treat. 1991;8(1-2):29-33. doi: 10.1016/0740-5472(91)90024-5. J Subst Abuse Treat. 1991. PMID: 1675689 Review.
Cited by
-
Effects of continuous diazepam administration on GABAA subunit mRNA in rat brain.J Mol Neurosci. 1990;2(2):101-7. doi: 10.1007/BF02876917. J Mol Neurosci. 1990. PMID: 1964063
-
Decreased expression of gamma-aminobutyric acid type A/benzodiazepine receptor beta subunit mRNAs in brain of flurazepam-tolerant rats.J Mol Neurosci. 1994 Fall;5(3):181-92. doi: 10.1007/BF02736732. J Mol Neurosci. 1994. PMID: 7654520
-
Subunit- and brain region-specific reduction of GABAA receptor subunit mRNAs during chronic treatment of rats with diazepam.J Mol Neurosci. 1994 Summer;5(2):105-20. doi: 10.1007/BF02736752. J Mol Neurosci. 1994. PMID: 7710920
-
Déprescription des agonistes des récepteurs des benzodiazépines: Lignes directrices de pratique clinique fondées sur les données probantes.Can Fam Physician. 2018 May;64(5):e209-e224. Can Fam Physician. 2018. PMID: 29760269 Free PMC article. French.
-
Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists.Eur J Pharmacol. 2007 Jun 14;564(1-3):88-93. doi: 10.1016/j.ejphar.2007.02.006. Epub 2007 Feb 16. Eur J Pharmacol. 2007. PMID: 17368613 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Miscellaneous